Mr. Koo, as a CPA in Korea, has 26 years of experience in auditing, tax adjustment, and consulting on acquisitions and sales of many companies.

 

As a Magnaging Partner of Linea Investment, Mr. Koo decides key issues of the company, including finding the deals and the following fundraising.

 

Before joining Linea Investment, Mr. Koo was the Representative of Seo-cho Branch in Jinil Accounting Firm, where he invested to USA Rare Earth, a mining company as well as K2B Bio Therapeutics, a US biotech company with successful fund rasising.

 

Prior to joining Jinil, Mr. Koo served as CEO of Jungil Accounting Firm, where he raised about $10 million capital into TissueGene, a US biopharmaceutical company and performed advisory services for IPO when the company was listed on the KOSDAQ in 2017. During his time at Jungil, Mr. Koo also raised funds for WCCT Global, Cognate BioServices, WindMIL Therapeutics, Genosco, etc.

 

Mr. Koo received his B.A. in business administration from SungKyunKwan University and EMBA from William & Mary University.

Mr. Lee has over ten years of equity fund management and unlisted stock investment experience in various industries.

 
At Linea Investment, he oversees investments based on macroeconomic analysis, an in-depth understanding of various industries, and an analysis of the corporate business.

 
Before joining Linea Investment, Mr. Lee managed Wrap accounts, IPO funds, and equity funds in NH Investment & Securities, Square Investment Management, VI Asset Management, and Taurus Asset Management. Mr. Lee also worked at Samil PwC as a KICPA.

 
Mr. Lee received his bachelor’s degree in Business Administration from Korea University in Seoul, Korea.

Ms. Sohn has over 10 years of experience in an investment company.

 

As a Director of Medivate Partners, Ms. Sohn is in charge of administrative works related to PEF.

 

Prior to joining Medivate Partners, Ms. Sohn worked at Newlake Alliance Management and Keystone Private Equity.

 

Ms. Sohn received her BA in Business Administration from Ewha Womans University in Seoul, Korea.

Mr. Jung is a seasoned financial professioal with proved track records in overseas financial institutions and accounting firms for more than 10 years.

 

At Linea, he reviews deals and manages investment portfolio, focusing on market research, industry trend analysis, and potential risk identification.

 

He previously performed valuation of financial instruments at the Federal Home Loan Bank. He also assessed corporate credit ratings at Sumitomo Mitsui Banking Corporation. Starting his career at PricewaterhouseCoopers Korea, he advised on M&A transactions and conducted corporate valuations.

 

Mr. Jung holds an MSc degree in economics from Johns Hopkins University, completed his MBA at Indiana University, and is a CFA charterholder.

Mr. Oh has over ten years of experience in pharmaceutical industry as well as financing through clinical trial management and healthcare-focused equity fund investment and research.

At Linea Investment, he oversees due diligence and management of healthcare portfolio and focusing on market and industry research.

Prior to joining Linea Investment, Mr. Oh managed numerous clinical projects at AstraZeneca Korea as the clinical research associate and the local study leader. He also worked as healthcare sector analyst and Mertiz Securities and as healthcare portfolio manager and analyst at QUAD Investment Management.

 

Mr. Oh received his bachelor’s degree in Biomedical Science from University of Auckland, New Zealand. He also holds a master’s degree in Biomedical Science from Korea University in Seoul, Korea.

Mr. Lee has more than 2 years of experience in a private equity fund company.

 

As an assistant manager of Linea Investment, Mr.Lee is in charge of market research, due diligence  and fund management.

 

Prior to joining Linea Investment, Mr.Lee performed IB and IPO advisory services for overseas bio companies at KNT Investment.

 

Mr.Lee received a bachelor's degree in Finance/Accounting from the University of Auckland, New Zealand.

Ms. Yu has over 5 years of experience in office finance management.

 

At Linea Investment, Ms. Yu is in charge of supporting management including fund-related administrative works and accounting.

 

Before joining Linea Investment, Ms. Yu worked at Osan University and Dooroocelltech.

Dr. Joseph Kim has over 25 years of experience in senior legal roles in the United States.

 

He is currently a partner at FisherBroyles, LLP, where his responsibilities include oversight and strengthening of companies’ patent portfolios. He manages international patent portfolios for start-up, mid-size, and academic clients.

 

Dr. Kim received an AB from Princeton University (Biochemistry), a PhD from The Johns Hopkins University (Molecular Biology), and a JD from University of Maryland. He is a registered patent attorney with the United States Patent & Trademark Office and is licensed to practice in California and Maryland.